July 4 (UPI) --Doctors in Britain will begin the world's first study involving MDMA's effects on alcohol addiction. The study's aim is to find out whether small doses of MDMA, most commonly used in ...
A psychedelic drug holds so much potential to improve treatment of post-traumatic stress disorder that some Philadelphia-area patients may get it before the U.S. Food and Drug Administration gives ...
In the late 1970s and early 1980s MDMA was often utilized to help facilitate positive results in couples counseling. A few dozen pioneering psychotherapists in the United States explored the drug’s ...
The agency’s staff analysis suggests that approval of the illegal drug known as Ecstasy for treatment of PTSD is far from certain, with advisers meeting next week to consider the proposed therapy. By ...
A small new study has shown how MDMA could help reduce social anxiety in people with autism. 12 participants took part in the research, and those who had MDMA-assisted therapy reported more of an ...
MDMA, or ecstasy, once had the reputation of exclusively being an illicit party drug popular at raves and dance clubs. That view has changed in recent years. The substance, known for its ability to ...
The clinical trial investigating the effects of MDMA analogs in healthy volunteers led by PI Prof. Dr. Matthias Liechti and supported by psychedelics biotech company Mind Medicine Inc. MNMD has begun ...
The drug MDMA has had some highs and lows since United States lawmakers made it illegal in 1985. Also known as ‘ecstasy,’ the drug made a name for itself as the fuel for the party scene of the 1990s.
Exclusive sex parties fueled by psychoactive drugs are apparently how the tech world elite like to get down in Silicon Valley, according to an excerpt from the Bloomberg reporter Emily Chang's new ...
The FDA is weighing whether to approve MDMA for PTSD. Here's what that could look like for patients.
Ahead of a key meeting Tuesday to weigh the potential approval of midomafetamine, or MDMA, for patients with post-traumatic stress disorder, the Food and Drug Administration is proposing a new set of ...
This week, the U.S. Food and Drug Administration granted researchers permission to move forward with a study plan for a large-scale phase three clinical trial studying the effects of MDMA as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback